HTL-Strefa Responds to Growing Calls for Affordable Healthcare With Cost-Effective Diabetes Solutions

Press Release • Oct 4, 2024 08:00 EDT

Amidst recent news on healthcare pricing, HTL-Strefa, part of the MTD Group, reinforces its commitment to delivering innovative, high-quality pen needles at lower costs, with the Droplet brand rapidly expanding across U.S. markets

WOODSTOCK, Ga., October 4, 2024 (Newswire.com) - As you may have seen in recent news, there is growing pressure to make healthcare more affordable to patients. Core to our strategy at HTL-Strefa, an MTD company, is a relentless focus on reducing costs for the healthcare system while providing solutions that meet the top-notch quality standards.   

HTL-Strefa, as part of the MTD Group, benefits from MTD’s global leadership in med tech, with vertically integrated manufacturing in Europe for a large part of its branded products related to the diabetes business (pen needles, safety pen needles, safety lancets, etc). This setup ensures upscale control over production processes, maintaining high quality while offering cost-efficient solutions. MTD Group is today the second-largest worldwide producer of pen needles and safety pen needles, with HTL-Strefa’s Droplet brand standing out as the fastest-growing pen needle brand in the U.S.* Our products are widely available at many retailers, including several national pharmacy chains. In addition to our focus on quality and cost, we are very focused on product innovation, such as Droplet Micron, the thinnest and shortest pen needle on the market. 

To learn more about HTL Strefa and MTD  Group and partnering with us to reduce the financial burden on healthcare systems, visit our site https://mydroplet.com/  or contact us at info@htl-strefa.com

About MTD: https://mtdglobal.com/north-america

* IQVIA Manufacturer Volume Trend, Nov 22. Data on File     

Source: HTL-Strefa

Tags

About HTL-STREFA, Inc., an MTD company

HTL-Strefa, Inc. is a subsidiary of MTD (Medical Technology and Devices). MTD is a med-tech global leader which designs, develops and provides a full range of medical devices for home & professional care. MTD offers both patients and healthcare professionals a broad range of medical devices and personal care solutions. MTD has several modern production facilities in Poland & Italy, as well as Commercial offices located in Warsaw Poland, Grandate Italy, and Woodstock, GA (USA).

The MTD group was founded in 2018, when two leading healthcare companies with a long-standing med-tech heritage joined forces. One of these companies was HTL-Strefa, a world leader in designing, developing and producing diabetes products for drug delivery and capillary blood sampling, with a core expertise in safety sharps. HTL-Strefa is widely recognized as the inventor of the “safety lancet” product category.


HTL-Strefa, Inc. is the North American subsidiary of MTD, and distributes products that are used in various diagnostic tests performed by hospitals, clinics, and laboratories.

Under the brands Droplet and DropSafe, HTL-Strefa Inc .currently supplies pen needles and insulin syringes, safety lancets, safety pen needles, and immunization products. Droplet is widely recognized as the fastest growing pen needle brand and the #2 largest pen needle supplier in North America.

Information on our latest innovations can be found on our brand websites: www.mydroplet.com and www.dropsafe.info

Website
https://mtdglobal.com/

mtdglobal.com
HTL-STREFA, Inc., an MTD company
113 TOWNE LAKE PKWY , #Suite 120
WOODSTOCK, GA
30188

Contacts

More Press Releases